Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Barbagelata

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|October 8, 2005
Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmiasSusan Elizabeth Shoaf, Marcelo Víctor Elizari, Zhao Wang, et al.
Journal of Electrocardiology|May 5, 2007
Time to reperfusion in acute myocardial infarction. It is time to reduce it!Alejandro Barbagelata, Eduardo R Perna, Peter Clemmensen, et al.
Cardiology in Review|July 1, 2026
Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-AnalysisNorma N Gamarra-Valverde, Susimar Picado Loaiza, Maryam Asif, et al.
Sleep & Breathing = Schlaf & Atmung|April 24, 2026
Efficacy of GLP-1 Receptor agonists in treating Obstructive sleep apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomesMrunalini Dandamudi, Larissa Lucena, Nicole Norma Gamarra-Valverde, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
American Heart Journal|October 8, 2005
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trialAlejandro Barbagelata, Marcelo F Di Carli, Robert M Califf, et al.
Current Diabetes Reports|March 10, 2026
Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes : Incretin Therapy in T2DM and PADLarissa Araújo de Lucena, Deivyd V S Cavalcante, Marcela V Montenegro, et al.
Current Diabetes Reports|April 10, 2026
Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality OutcomesLarissa Araújo de Lucena, Deivyd V S Cavalcante, Marcela V Montenegro, et al.
Circulation|October 13, 2004
Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identificationEduardo R Perna, Stella M Macin, Juan P Cimbaro Canella, et al.
European Journal of Internal Medicine|May 23, 2026
Device-based therapies for cardiorenal syndrome: A comprehensive, mechanism-driven framework for next-generation decongestionJuliana Giorgi, Salomon Chamay, Caroline O Fischer-Bacca, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology and Therapeutics|October 8, 2005
Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmiasSusan Elizabeth Shoaf, Marcelo Víctor Elizari, Zhao Wang, et al.
Journal of Electrocardiology|May 5, 2007
Time to reperfusion in acute myocardial infarction. It is time to reduce it!Alejandro Barbagelata, Eduardo R Perna, Peter Clemmensen, et al.
Cardiology in Review|July 1, 2026
Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-AnalysisNorma N Gamarra-Valverde, Susimar Picado Loaiza, Maryam Asif, et al.
Sleep & Breathing = Schlaf & Atmung|April 24, 2026
Efficacy of GLP-1 Receptor agonists in treating Obstructive sleep apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomesMrunalini Dandamudi, Larissa Lucena, Nicole Norma Gamarra-Valverde, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
American Heart Journal|October 8, 2005
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trialAlejandro Barbagelata, Marcelo F Di Carli, Robert M Califf, et al.
Current Diabetes Reports|March 10, 2026
Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes : Incretin Therapy in T2DM and PADLarissa Araújo de Lucena, Deivyd V S Cavalcante, Marcela V Montenegro, et al.
Current Diabetes Reports|April 10, 2026
Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality OutcomesLarissa Araújo de Lucena, Deivyd V S Cavalcante, Marcela V Montenegro, et al.
Circulation|October 13, 2004
Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identificationEduardo R Perna, Stella M Macin, Juan P Cimbaro Canella, et al.
European Journal of Internal Medicine|May 23, 2026
Device-based therapies for cardiorenal syndrome: A comprehensive, mechanism-driven framework for next-generation decongestionJuliana Giorgi, Salomon Chamay, Caroline O Fischer-Bacca, et al.
Pageof 6